New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 14, 2012
07:12 EDTCVSCVS Caremark upgraded to Outperform from Neutral at Macquarie
Macquarie expects CVS Caremark's long-term growth to benefit from Healthcare reform laws and for shares to outperform based on limited 2013 negative earnings revisions, a stronger 2014 PBM selling season, and generics. Price target raised to $55 from $50.
News For CVS From The Last 14 Days
Check below for free stories on CVS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CVS

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use